It may indicate that tumor cells can exploit regulators, such as CTLA-4, and PD-1, that involved in above identified pathways to engage T cells to generate immunosuppressive microenvironment, which contributed to the pathogenesis and progression of AML. This evidence concerns the gene CTLA4 and acute myeloid leukemia.